STOCK TITAN

Phibro Animal Health (NASDAQ: PAHC) GC sells 472 shares for taxes

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PHIBRO ANIMAL HEALTH CORP executive Judith Weinstein reported an other disposition of 472 shares of Class A Common Stock on August 4, 2026, at $36.599 per share. According to the filing, these shares were sold in a broker-assisted cashless exercise to satisfy tax withholding obligations upon vesting and settlement of restricted stock units. Following this transaction, Weinstein directly held 2,975 shares of Class A Common Stock. The transaction was not reported as occurring under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Weinstein Judith
Role See Remarks
Type Security Shares Price Value
Other Class A Common Stock F1 472 $36.599 $17K
Holdings After Transaction: Class A Common Stock — 2,975 shares (Direct)
Footnotes (1)
  1. F1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Shares disposed 472 shares Class A Common Stock transaction on August 4, 2026
Transaction price $36.599 per share Broker-assisted cashless sale to satisfy tax withholding
Shares held after transaction 2,975 shares Direct ownership of Class A Common Stock following reported disposition
broker assisted cashless exercise program financial
"Represents shares sold in a broker assisted cashless exercise program to satisfy tax"
tax withholding obligations financial
"exercise program to satisfy tax withholding obligations upon the receipt of Class A"
restricted stock units financial
"receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did PAHC executive Judith Weinstein report?

Judith Weinstein reported an other disposition of 472 shares of Phibro Animal Health Class A Common Stock. The shares were sold in a broker-assisted cashless exercise to cover tax withholding tied to vesting and settlement of restricted stock units.

At what price were the 472 PAHC shares associated with Judith Weinstein’s transaction valued?

The 472 Phibro Animal Health shares were valued at $36.599 per share. This price applies to the broker-assisted cashless sale used to satisfy Weinstein’s tax withholding obligations when her restricted stock units vested and settled.

How many PAHC shares does Judith Weinstein hold after this reported transaction?

After the transaction, Judith Weinstein directly holds 2,975 shares of Phibro Animal Health Class A Common Stock. This figure reflects her position following the 472-share tax-related disposition reported in the filing.

Was Judith Weinstein’s PAHC share transaction executed under a Rule 10b5-1 trading plan?

No. The filing indicates the Rule 10b5-1 checkbox was not marked, so the transaction was not reported as occurring under a pre-arranged Rule 10b5-1 trading plan, but rather as a tax-related cashless sale.

What was the purpose of Judith Weinstein’s 472-share PAHC disposition?

The 472 shares were sold in a broker-assisted cashless exercise to satisfy tax withholding obligations. This occurred when Judith Weinstein received Class A Common Stock in connection with the vesting and settlement of her restricted stock units.

What role does Judith Weinstein hold at Phibro Animal Health (PAHC)?

Judith Weinstein serves as Senior Vice President, General Counsel and Corporate Secretary of Phibro Animal Health. The reported equity transaction relates to her compensation in the form of restricted stock units.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weinstein Judith

(Last)(First)(Middle)
300 FRANK W. BURR BLVD., STE 21

(Street)
TEANECK NEW JERSEY 07666

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PHIBRO ANIMAL HEALTH CORP [ PAHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock08/04/2026J472(1)D$36.5992,975D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.
Remarks:
Senior Vice President, General Counsel and Corporate Secretary.
/s/ Judith Weinstein08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)